Supply Chain

Novo Mike Doustdar 2
Favicon Fierce Pharma

Novo struggles to appease restless investors with new strategy

CEO Mike Doustdar acknowledged that the company’s leadership “have to convince” investors that “there is a bright future for Novo.”
NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am
Jake Leach

Dexcom CEO outlines plan to stop a repeat of G7 supply shortage

Jan 13, 2026 8:10am
future forward-looking 2026 new year

Pharma's 'urgent need for reinvention': PwC's call to action

Jan 8, 2026 6:00am
WuXi
Favicon Fierce Pharma

WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg

Dec 4, 2025 8:55am
Rise increase upward trajectory arrow ascent ascending
Favicon Fierce Pharma

Teva debuts innovation platform to parry key industry challenges

Nov 19, 2025 8:38am